Amundi
SILK

Amundi’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Amundi’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-195,232
Closed -$6.24M – 2076
2023
Q2 		$6.24M Buy
195,232
+71,036
+57% +$2.59M ﹤0.01% 937
2023
Q1 		$4.9M Sell
124,196
-236,359
-66% -$11.6M ﹤0.01% 998
2022
Q4 		$19.3M Sell
360,555
-11,066
-3% -$539K 0.01% 704
2022
Q3 		$17.7M Sell
371,621
-96,514
-21% -$4.15M 0.01% 722
2022
Q2 		$17.3M Sell
468,135
-37,783
-7% -$1.37M 0.01% 654
2022
Q1 		$22.1M Buy
505,918
+85,623
+20% +$3.01M 0.02% 632
2021
Q4 		$15.6M Sell
420,295
-158,298
-27% -$7.92M 0.01% 740
2021
Q3 		$31.8M Buy
578,593
+90,913
+19% +$4.76M 0.02% 560
2021
Q2 		$23.3M Buy
+487,680
New +$24.8M 0.02% 638

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Amundi's SILK Position: Q3 2023 in Review

Amundi sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2023, closing a stake of 195,232 shares — an estimated $6.24M sold.

Amundi first reported a position in SILK in Q2 2021 and held it in 9 quarters. The position peaked at $31.8M in Q3 2021. 166 funds tracked by Wall St. Rank hold SILK as of Q3 2023.

  • Amundi reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Amundi sold 195,232 Silk Road Medical, Inc. Common Stock shares in Q3 2023, an estimated $6.24M.
  • Amundi first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
  • Amundi's Silk Road Medical, Inc. Common Stock position peaked at $31.8M in Q3 2021.
  • 166 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2023.

Based on Amundi's 13F filing for Q3 2023, filed 14 Nov 2023.